{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:11:04Z","timestamp":1792681864027,"version":"4.5.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s43032-025-02042-y","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:33:58Z","timestamp":1768926838000},"page":"496-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synergism on Cancer Development of Human Papillomavirus and Chlamydia Trachomatis Co-Infection"],"prefix":"10.1007","volume":"33","author":[{"given":"Erqun","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6706-279X","authenticated-orcid":false,"given":"Shuangyang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"2042_CR1","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nm1598","volume":"13","author":"JN Roberts","year":"2007","unstructured":"Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, et al. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med. 2007;13:857\u201361. https:\/\/doi.org\/10.1038\/nm1598.","journal-title":"Nat Med"},{"key":"2042_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664\u201370. https:\/\/doi.org\/10.1002\/ijc.30716.","journal-title":"Int J Cancer"},{"key":"2042_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/cs20050369","volume":"110","author":"J Doorbar","year":"2006","unstructured":"Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006;110:525\u201341. https:\/\/doi.org\/10.1042\/cs20050369.","journal-title":"Clin Sci (Lond)"},{"key":"2042_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrmicro.2016.30","volume":"14","author":"C Elwell","year":"2016","unstructured":"Elwell C, Mirrashidi K, Engel J. Chlamydia cell biology and pathogenesis. Nat Rev Microbiol. 2016;14:385\u2013400. https:\/\/doi.org\/10.1038\/nrmicro.2016.30.","journal-title":"Nat Rev Microbiol"},{"key":"2042_CR5","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1001\/jama.1990.03440230060033","volume":"263","author":"JM Chow","year":"1990","unstructured":"Chow JM, Yonekura ML, Richwald GA, Greenland S, Sweet RL, Schachter J. The association between chlamydia trachomatis and ectopic pregnancy. A matched-pair, case-control study. JAMA. 1990;263:3164\u20137.","journal-title":"JAMA"},{"key":"2042_CR6","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/0002-9378(91)90559-a","volume":"164","author":"W Cates Jr.","year":"1991","unstructured":"Cates W Jr., Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol. 1991;164:1771\u201381. https:\/\/doi.org\/10.1016\/0002-9378(91)90559-a.","journal-title":"Am J Obstet Gynecol"},{"key":"2042_CR7","doi-asserted-by":"publisher","unstructured":"Witkin SS, Minis E, Athanasiou A, Leizer J, Linhares IM. Chlamydia trachomatis: the persistent pathogen. Clin Vaccine Immunol. 2017;24. https:\/\/doi.org\/10.1128\/cvi.0020.","DOI":"10.1128\/cvi.0020"},{"key":"2042_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143304","volume":"10","author":"L Newman","year":"2015","unstructured":"Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10:e0143304. https:\/\/doi.org\/10.1371\/journal.pone.0143304.","journal-title":"PLoS One"},{"key":"2042_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.idc.2023.02.008","volume":"37","author":"RE Plotzker","year":"2023","unstructured":"Plotzker RE, Vaidya A, Pokharel U, Stier EA. Sexually transmitted human papillomavirus: update in epidemiology, prevention, and management. Infect Dis Clin North Am. 2023;37:289\u2013310. https:\/\/doi.org\/10.1016\/j.idc.2023.02.008.","journal-title":"Infect Dis Clin North Am"},{"key":"2042_CR10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3881\/j.issn.1000-503X.10636","volume":"40","author":"R Zhang","year":"2018","unstructured":"Zhang R, Zhou YL, Dou YL, Kong LJ, Ye AL, Wu J, et al. [Infection status of human papilloma virus, Ureaplasma Urealyticum, Chlamydia Trachomatis, and Neisseria Gonorrhoeae]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018;40:817\u201321. https:\/\/doi.org\/10.3881\/j.issn.1000-503X.10636.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"2042_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12879-024-09094-6","volume":"24","author":"Y Lu","year":"2024","unstructured":"Lu Y, Wu Q, Wang L, Ji L. Chlamydia trachomatis enhances HPV persistence through immune modulation. BMC Infect Dis. 2024;24:229. https:\/\/doi.org\/10.1186\/s12879-024-09094-6.","journal-title":"BMC Infect Dis"},{"key":"2042_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.105971","volume":"175","author":"L Ferrera","year":"2023","unstructured":"Ferrera L, Rogua H, El Mansouri N, Kassidi F, Aksim M, El Farouqi A, et al. The association of Chlamydia trachomatis and human papillomavirus co-infection with abnormal cervical cytology among women in south of Morocco. Microb Pathog. 2023;175:105971. https:\/\/doi.org\/10.1016\/j.micpath.2023.105971.","journal-title":"Microb Pathog"},{"key":"2042_CR13","first-page":"34","volume":"41","author":"M Di Pietro","year":"2018","unstructured":"Di Pietro M, Filardo S, Porpora MG, Recine N, Latino MA, Sessa R. HPV\/Chlamydia trachomatis co-infection: metagenomic analysis of cervical microbiota in asymptomatic women. New Microbiol. 2018;41:34\u201341.","journal-title":"New Microbiol"},{"key":"2042_CR14","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/s41467-022-28569-1","volume":"13","author":"S Koster","year":"2022","unstructured":"Koster S, Gurumurthy RK, Kumar N, Prakash PG, Dhanraj J, Bayer S, Berger H, Kurian SM, Drabkina M, Mollenkopf HJ, Goosmann C, Brinkmann V, Nagel Z, Mangler M, Meyer TF, Chumduri C. Modelling chlamydia and HPV co-infection in patient-derived ectocervix organoids reveals distinct cellular reprogramming. Nat Commun. 2022;13:1030. https:\/\/doi.org\/10.1038\/s41467-022-28569-1.","journal-title":"Nat Commun"},{"key":"2042_CR15","doi-asserted-by":"publisher","first-page":"1214017","DOI":"10.3389\/fcimb.2023.1214017","volume":"13","author":"C Olivera","year":"2023","unstructured":"Olivera C, Mosmann JP, Anna AN, Bettucci Ferrero GN, Paira DA, Ferreyra FN, et al. Expression of HPV-16 E6 and E7 oncoproteins alters chlamydia trachomatis developmental cycle and induces increased levels of immune regulatory molecules. Front Cell Infect Microbiol. 2023;13:1214017. https:\/\/doi.org\/10.3389\/fcimb.2023.1214017.","journal-title":"Front Cell Infect Microbiol"},{"key":"2042_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103108","volume":"71","author":"Q Meng","year":"2024","unstructured":"Meng Q, Zhang Y, Sun H, Yang X, Hao S, Liu B, et al. Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation. Redox Biol. 2024;71:103108. https:\/\/doi.org\/10.1016\/j.redox.2024.103108.","journal-title":"Redox Biol"},{"key":"2042_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.4049\/jimmunol.1301657","volume":"192","author":"SC Fankhauser","year":"2014","unstructured":"Fankhauser SC, Starnbach MN. PD-L1 limits the mucosal CD8\u2009+\u2009T cell response to Chlamydia trachomatis. J Immunol. 2014;192:1079\u201390. https:\/\/doi.org\/10.4049\/jimmunol.1301657.","journal-title":"J Immunol"},{"key":"2042_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/archpedi.160.2.151","volume":"160","author":"ML Shew","year":"2006","unstructured":"Shew ML, Fortenberry JD, Tu W, Juliar BE, Batteiger BE, Qadadri B, Brown DR. Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women. Arch Pediatr Adolesc Med. 2006;160:151\u20136. https:\/\/doi.org\/10.1001\/archpedi.160.2.151.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2042_CR19","doi-asserted-by":"publisher","first-page":"e0279390","DOI":"10.1371\/journal.pone.0279390","volume":"18","author":"LZA Lugo","year":"2023","unstructured":"Lugo LZA, Puga MAM, Jacob CMB, Padovani CTJ, Nocetti MC, Tupin\u00e1 MS, et al. Cytokine profiling of samples positive for chlamydia trachomatis and human papillomavirus. PLoS One. 2023;18:e0279390. https:\/\/doi.org\/10.1371\/journal.pone.0279390.","journal-title":"PLoS One"},{"key":"2042_CR20","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/cam4.496","volume":"4","author":"HJ Vriend","year":"2015","unstructured":"Vriend HJ, Bogaards JA, van Bergen JE, Brink AA, van den Broek IV, Hoebe CJ, King AJ, van der Sande MA, Wolffs PF, de Melker HE. Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without chlamydia trachomatis co-infection. Cancer Med. 2015;4:1589\u201398. https:\/\/doi.org\/10.1002\/cam4.496.","journal-title":"Cancer Med"},{"key":"2042_CR21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10096-004-1194-5","volume":"23","author":"V Verhoeven","year":"2004","unstructured":"Verhoeven V, Baay M, Weyler J, Avonts D, Lardon F, Van Royen P, Vermorken JB. Concomitant chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour. Eur J Clin Microbiol Infect Dis. 2004;23:735\u20137. https:\/\/doi.org\/10.1007\/s10096-004-1194-5.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2042_CR22","doi-asserted-by":"publisher","unstructured":"Koskela P, Anttila T, Bj\u00f8rge T, Brunsvig A, Dillner J, Hakama M, Hakulinen T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala E, Saikku P, Thoresen S, Youngman L, Paavonen J. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer. 2000;85(20000101). https:\/\/doi.org\/10.1002\/(sici)1097-0215(20000101)85:1%3C;35::aid-ijc6%3E;3.0.co;2-a.","DOI":"10.1002\/(sici)1097-0215(20000101)85:1%3C;35::aid-ijc6%3E;3.0.co;2-a"},{"key":"2042_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12905-023-02259-6","volume":"23","author":"Z Lu","year":"2023","unstructured":"Lu Z, Zhao P, Lu H, Xiao M. Analyses of human papillomavirus, chlamydia trachomatis, Ureaplasma urealyticum, neisseria gonorrhoeae, and co-infections in a gynecology outpatient clinic in Haikou area, China. BMC Womens Health. 2023;23:117. https:\/\/doi.org\/10.1186\/s12905-023-02259-6.","journal-title":"BMC Womens Health"},{"key":"2042_CR24","doi-asserted-by":"publisher","first-page":"c57","DOI":"10.7759\/cureus.c57","volume":"14","author":"AP Arcia Franchini","year":"2022","unstructured":"Arcia Franchini AP, Iskander B, Anwer F, Oliveri F, Fotios K, Panday P, Hamid P. Correction: The role of chlamydia trachomatis in the pathogenesis of cervical cancer. Cureus. 2022;14:c57. https:\/\/doi.org\/10.7759\/cureus.c57.","journal-title":"Cureus"},{"key":"2042_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/infdis\/jiy497","volume":"219","author":"Y Ji","year":"2019","unstructured":"Ji Y, Ma XX, Li Z, Peppelenbosch MP, Ma Z, Pan Q. The burden of human papillomavirus and chlamydia trachomatis coinfection in women: a large cohort study in inner Mongolia, China. J Infect Dis. 2019;219:206\u201314. https:\/\/doi.org\/10.1093\/infdis\/jiy497.","journal-title":"J Infect Dis"},{"key":"2042_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/sextrans-2016-053046","volume":"94","author":"LJ Menezes","year":"2018","unstructured":"Menezes LJ, Pokharel U, Sudenga SL, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, van der Schim MF, van der Laan LE, Kipping S, Taylor D, Giuliano AR. Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial. Sex Transm Infect. 2018;94:55\u201361. https:\/\/doi.org\/10.1136\/sextrans-2016-053046.","journal-title":"Sex Transm Infect"},{"key":"2042_CR27","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/aje\/kwi262","volume":"162","author":"E Samoff","year":"2005","unstructured":"Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, et al. Association of chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol. 2005;162:668\u201375. https:\/\/doi.org\/10.1093\/aje\/kwi262.","journal-title":"Am J Epidemiol"},{"key":"2042_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/sti.58.6.366","volume":"58","author":"S Darougar","year":"1982","unstructured":"Darougar S, Forsey T, Osoba AO, Dines RJ, Adelusi B, Coker GO. Chlamydial genital infection in Ibadan, Nigeria. A seroepidemiological survey. Br J Vener Dis. 1982;58:366\u20139. https:\/\/doi.org\/10.1136\/sti.58.6.366.","journal-title":"Br J Vener Dis"},{"key":"2042_CR29","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00284-018-1439-7","volume":"75","author":"S Karim","year":"2018","unstructured":"Karim S, Souho T, Benlemlih M, Bennani B. Cervical cancer induction enhancement potential of chlamydia trachomatis: a systematic review. Curr Microbiol. 2018;75:1667\u201374. https:\/\/doi.org\/10.1007\/s00284-018-1439-7.","journal-title":"Curr Microbiol"},{"key":"2042_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105587","volume":"168","author":"S Kumari","year":"2022","unstructured":"Kumari S, Bhor VM. A literature review on correlation between HPV coinfection with C. trachomatis and cervical neoplasia - coinfection mediated cellular transformation. Microb Pathog. 2022;168:105587. https:\/\/doi.org\/10.1016\/j.micpath.2022.105587.","journal-title":"Microb Pathog"},{"key":"2042_CR31","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/modpathol.2015.108","volume":"28","author":"L Mezache","year":"2015","unstructured":"Mezache L, Paniccia B, Nyinawabera A, Nuovo GJ. Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers. Mod Pathol. 2015;28:1594\u2013602. https:\/\/doi.org\/10.1038\/modpathol.2015.108.","journal-title":"Mod Pathol"},{"key":"2042_CR32","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3892\/mmr.2017.6102","volume":"15","author":"C Liu","year":"2017","unstructured":"Liu C, Lu J, Tian H, Du W, Zhao L, Feng J, et al. Increased expression of PD\u2011L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity. Mol Med Rep. 2017;15:1063\u201370. https:\/\/doi.org\/10.3892\/mmr.2017.6102.","journal-title":"Mol Med Rep"},{"key":"2042_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-020-01027-5","volume":"14","author":"M Yi","year":"2021","unstructured":"Yi M, Niu M, Xu L, Luo S, Wu K. Regulation of PD-L1 expression in the tumor microenvironment. J Hematol Oncol. 2021;14:10. https:\/\/doi.org\/10.1186\/s13045-020-01027-5.","journal-title":"J Hematol Oncol"},{"key":"2042_CR34","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1200\/jco.18.01265","volume":"37","author":"HC Chung","year":"2019","unstructured":"Chung HC, Ros W, Delord JP, Perets R, Italiano A, Shapira-Frommer R, et al. Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol. 2019;37:1470\u20138. https:\/\/doi.org\/10.1200\/jco.18.01265.","journal-title":"J Clin Oncol"},{"key":"2042_CR35","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1200\/jco.23.00914","volume":"41","author":"BJ Monk","year":"2023","unstructured":"Monk BJ, Colombo N, Tewari KS, Dubot C, Caceres MV, Hasegawa K, et al. First-line pembrolizumab\u2009+\u2009chemotherapy versus placebo\u2009+\u2009chemotherapy for persistent, recurrent, or metastatic cervical cancer: final overall survival results of KEYNOTE-826. J Clin Oncol. 2023;41:5505\u201311. https:\/\/doi.org\/10.1200\/jco.23.00914.","journal-title":"J Clin Oncol"},{"key":"2042_CR36","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1056\/NEJMoa2112187","volume":"386","author":"KS Tewari","year":"2022","unstructured":"Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, et al. Survival with cemiplimab in recurrent cervical cancer. N Engl J Med. 2022;386:544\u201355. https:\/\/doi.org\/10.1056\/NEJMoa2112187.","journal-title":"N Engl J Med"},{"key":"2042_CR37","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1158\/1055-9965.Epi-15-0420","volume":"24","author":"MG Discacciati","year":"2015","unstructured":"Discacciati MG, Gimenes F, Pennacchi PC, Fai\u00e3o-Flores F, Zeferino LC, Derchain SM, et al. MMP-9\/RECK imbalance: a mechanism associated with high-grade cervical lesions and genital infection by human papillomavirus and chlamydia trachomatis. Cancer Epidemiol Biomarkers Prev. 2015;24:1539\u201347. https:\/\/doi.org\/10.1158\/1055-9965.Epi-15-0420.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2042_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","volume":"147","author":"N Cui","year":"2017","unstructured":"Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1\u201373. https:\/\/doi.org\/10.1016\/bs.pmbts.2017.02.005.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2042_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161\u201374. https:\/\/doi.org\/10.1038\/nrc745.","journal-title":"Nat Rev Cancer"},{"key":"2042_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52\u201367. https:\/\/doi.org\/10.1016\/j.cell.2010.03.015.","journal-title":"Cell"},{"key":"2042_CR41","doi-asserted-by":"publisher","first-page":"e0145198","DOI":"10.1371\/journal.pone.0145198","volume":"10","author":"JU Igietseme","year":"2015","unstructured":"Igietseme JU, Omosun Y, Stuchlik O, Reed MS, Partin J, He Q, et al. Role of epithelial-mesenchyme transition in chlamydia pathogenesis. PLoS ONE. 2015;10:e0145198. https:\/\/doi.org\/10.1371\/journal.pone.0145198.","journal-title":"PLoS ONE"},{"key":"2042_CR42","doi-asserted-by":"publisher","first-page":"11620","DOI":"10.18632\/oncotarget.2599","volume":"5","author":"W Liu","year":"2014","unstructured":"Liu W, Gao G, Hu X, Wang Y, Schwarz JK, Chen JJ, Grigsby PW, Wang X. Activation of miR-9 by human papillomavirus in cervical cancer. Oncotarget. 2014;5:11620\u201330. https:\/\/doi.org\/10.18632\/oncotarget.2599.","journal-title":"Oncotarget"},{"key":"2042_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2474235","volume":"2020","author":"M Liu","year":"2020","unstructured":"Liu M, Wang W, Chen H, Lu Y, Yuan D, Deng Y, et al. miR-9, miR-21, miR-27b, and miR-34a expression in HPV16\/58\/52-infected cervical cancer. BioMed Res Int. 2020;2020:2474235. https:\/\/doi.org\/10.1155\/2020\/2474235.","journal-title":"BioMed Res Int"},{"key":"2042_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ncb2024","volume":"12","author":"L Ma","year":"2010","unstructured":"Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA. miR-9, a MYC\/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010;12:247\u201356. https:\/\/doi.org\/10.1038\/ncb2024.","journal-title":"Nat Cell Biol"},{"key":"2042_CR45","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1158\/0008-5472.Can-10-1546","volume":"70","author":"X Zhang","year":"2010","unstructured":"Zhang X, Gu L, Li J, Shah N, He J, Yang L, Hu Q, Zhou M. Degradation of MDM2 by the interaction between Berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res. 2010;70:9895\u2013904. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-1546 .","journal-title":"Cancer Res"},{"key":"2042_CR46","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.7150\/jca.39996","volume":"11","author":"S Kumar","year":"2020","unstructured":"Kumar S, Tchounwou PB. Trisenox disrupts MDM2-DAXX-HAUSP complex and induces apoptosis in a mouse model of acute leukemia. J Cancer. 2020;11:4373\u201383. https:\/\/doi.org\/10.7150\/jca.39996.","journal-title":"J Cancer"},{"key":"2042_CR47","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63:1129\u201336. https:\/\/doi.org\/10.1016\/0092-8674(90)90409-8.","journal-title":"Cell"},{"key":"2042_CR48","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature16481","volume":"529","author":"D Martinez-Zapien","year":"2016","unstructured":"Martinez-Zapien D, Ruiz FX, Poirson J, Mitschler A, Ramirez J, Forster A, Cousido-Siah A, Masson M, Vande Pol S, Podjarny A, Trav\u00e9 G, Zanier K. Structure of the E6\/E6AP\/p53 complex required for HPV-mediated degradation of p53. Nature. 2016;529:541\u20135. https:\/\/doi.org\/10.1038\/nature16481.","journal-title":"Nature"},{"key":"2042_CR49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s11658-020-00230-z","volume":"25","author":"S Tang","year":"2020","unstructured":"Tang S, Ding S, Yu L, Shen H, Wan Y, Wu Y. Effects of HPV16 E6 protein on Daxx-induced apoptosis in C33A cells. Cell Mol Biol Lett. 2020;25:38. https:\/\/doi.org\/10.1186\/s11658-020-00230-z.","journal-title":"Cell Mol Biol Lett"},{"key":"2042_CR50","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1038\/ncomms6201","volume":"5","author":"E Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez E, Rother M, Kerr MC, Al-Zeer MA, Abu-Lubad M, Kessler M, Brinkmann V, Loewer A, Meyer TF. Chlamydia infection depends on a functional MDM2-p53 axis. Nat Commun. 2014;5:5201. https:\/\/doi.org\/10.1038\/ncomms6201.","journal-title":"Nat Commun"},{"key":"2042_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105929","volume":"175","author":"N Challagundla","year":"2023","unstructured":"Challagundla N, Chrisophe-Bourdon J, Agrawal-Rajput R. Chlamydia trachomatis infection co-operatively enhances HPV E6-E7 oncogenes mediated tumorigenesis and immunosuppression. Microb Pathog. 2023;175:105929. https:\/\/doi.org\/10.1016\/j.micpath.2022.105929.","journal-title":"Microb Pathog"},{"key":"2042_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042017","author":"PH Chen","year":"2022","unstructured":"Chen PH, Tjong WY, Yang HC, Liu HY, Stern A, Chiu DT. Glucose-6-phosphate dehydrogenase, redox homeostasis and embryogenesis. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23042017.","journal-title":"Int J Mol Sci"},{"key":"2042_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.718781","volume":"11","author":"YF Chang","year":"2021","unstructured":"Chang YF, Yan GJ, Liu GC, Hong Y, Chen HL, Jiang S, et al. HPV16 E6 promotes the progression of HPV infection-associated cervical cancer by upregulating glucose-6-phosphate dehydrogenase expression. Front Oncol. 2021;11:718781. https:\/\/doi.org\/10.3389\/fonc.2021.718781.","journal-title":"Front Oncol"},{"key":"2042_CR54","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.celrep.2014.10.004","volume":"9","author":"C Siegl","year":"2014","unstructured":"Siegl C, Prusty BK, Karunakaran K, Wischhusen J, Rudel T. Tumor suppressor p53 alters host cell metabolism to limit chlamydia trachomatis infection. Cell Rep. 2014;9:918\u201329. https:\/\/doi.org\/10.1016\/j.celrep.2014.10.004.","journal-title":"Cell Rep"},{"key":"2042_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13397","volume":"23","author":"K Wang","year":"2021","unstructured":"Wang K, Mu\u00f1oz KJ, Tan M, S\u00fctterlin C. Chlamydia and HPV induce centrosome amplification in the host cell through additive mechanisms. Cell Microbiol. 2021;23:e13397. https:\/\/doi.org\/10.1111\/cmi.13397.","journal-title":"Cell Microbiol"},{"key":"2042_CR56","doi-asserted-by":"publisher","first-page":"508","DOI":"10.18502\/ijph.v51i3.8926","volume":"51","author":"A Bhuvanendran Pillai","year":"2022","unstructured":"Bhuvanendran Pillai A, Mun Wong C, Dalila Inche Zainal Abidin N, Fazlinda Syed Nor S, Fathulzhafran Mohamed Hanan M, Rasidah Abd Ghani S, et al. Chlamydia infection as a risk factor for cervical cancer: a systematic review and meta-analysis. Iran J Public Health. 2022;51:508\u201317. https:\/\/doi.org\/10.18502\/ijph.v51i3.8926.","journal-title":"Iran J Public Health"},{"key":"2042_CR57","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1158\/0008-5472.Can-12-2384","volume":"73","author":"S Lyford-Pike","year":"2013","unstructured":"Lyford-Pike S, Peng S, Young GD, Taube JM, Westra WH, Akpeng B, Bruno TC, Richmon JD, Wang H, Bishop JA, Chen L, Drake CG, Topalian SL, Pardoll DM, Pai SI. Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. Cancer Res. 2013;73:1733\u201341. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-2384.","journal-title":"Cancer Res"},{"key":"2042_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet2023.216459","volume":"578","author":"N Kumar","year":"2023","unstructured":"Kumar N, Sethi G. Telomerase and hallmarks of cancer: an intricate interplay governing cancer cell evolution. Cancer Lett. 2023;578:216459. https:\/\/doi.org\/10.1016\/j.canlet2023.216459.","journal-title":"Cancer Lett"},{"key":"2042_CR59","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10555-016-9633-1","volume":"35","author":"P Boscolo-Rizzo","year":"2016","unstructured":"Boscolo-Rizzo P, Da Mosto MC, Rampazzo E, Giunco S, Del Mistro A, Menegaldo A, Baboci L, Mantovani M, Tirelli G, De Rossi A. Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications. Cancer Metastasis Rev. 2016;35:457\u201374. https:\/\/doi.org\/10.1007\/s10555-016-9633-1.","journal-title":"Cancer Metastasis Rev"},{"key":"2042_CR60","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1126\/science.277.5328.955","volume":"277","author":"TM Nakamura","year":"1997","unstructured":"Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. Telomerase catalytic subunit homologs from fission yeast and human. Science. 1997;277:955\u20139. https:\/\/doi.org\/10.1126\/science.277.5328.955.","journal-title":"Science"},{"key":"2042_CR61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.oooo.2020.02.015","volume":"130","author":"I Yilmaz","year":"2020","unstructured":"Yilmaz I, Erkul BE, Ozturk Sari S, Issin G, Tural E, Terzi Kaya Terzi N, Karatay H, Celik M, Ulusan M, Bilgic B. Promoter region mutations of the telomerase reverse transcriptase (TERT) gene in head and neck squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;130:63\u201370. https:\/\/doi.org\/10.1016\/j.oooo.2020.02.015.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2042_CR62","doi-asserted-by":"publisher","first-page":"17572","DOI":"10.1038\/s41598-019-54028-x","volume":"9","author":"P Boscolo-Rizzo","year":"2019","unstructured":"Boscolo-Rizzo P, Rampazzo E, Polesel J, Giunco S, Menegaldo A, Mantovani M, Stellin M, Bandolin L, Spinato G, Del Mistro A, Borsetto D, Fussey J, Tirelli G, Da Mosto MC, De Rossi A. Predictive and prognostic significance of telomerase levels\/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma. Sci Rep. 2019;9:17572. https:\/\/doi.org\/10.1038\/s41598-019-54028-x.","journal-title":"Sci Rep"},{"key":"2042_CR63","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.oraloncology.2015.02.100","volume":"51","author":"P Boscolo-Rizzo","year":"2015","unstructured":"Boscolo-Rizzo P, Rampazzo E, Perissinotto E, Piano MA, Giunco S, Baboci L, et al. Telomere shortening in mucosa surrounding the tumor: biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma. Oral Oncol. 2015;51:500\u20137. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.02.100.","journal-title":"Oral Oncol"},{"key":"2042_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246182","author":"KM Quist","year":"2021","unstructured":"Quist KM, Solorzano I, Wendel SO, Chintala S, Wu C, Wallace NA, et al. Cervical cancer development: implications of HPV16 E6E7-NFX1-123 regulated genes. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13246182.","journal-title":"Cancers (Basel)"},{"key":"2042_CR65","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1101\/gad.1214704","volume":"18","author":"L Gewin","year":"2004","unstructured":"Gewin L, Myers H, Kiyono T, Galloway DA. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6\/E6-AP complex. Genes Dev. 2004;18:2269\u201382. https:\/\/doi.org\/10.1101\/gad.1214704.","journal-title":"Genes Dev"},{"key":"2042_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28681","volume":"95","author":"A Wang","year":"2023","unstructured":"Wang A, Zhou D, Krawczyk E, Li T, Simic V, Lu J, et al. Overexpression of the telomerase holoenzyme induces EMT and tumorigenesis of HPV-immortalized keratinocytes. J Med Virol. 2023;95:e28681. https:\/\/doi.org\/10.1002\/jmv.28681.","journal-title":"J Med Virol"},{"key":"2042_CR67","doi-asserted-by":"publisher","first-page":"18780","DOI":"10.1073\/pnas.0906357106","volume":"106","author":"X Liu","year":"2009","unstructured":"Liu X, Dakic A, Zhang Y, Dai Y, Chen R, Schlegel R. HPV E6 protein interacts physically and functionally with the cellular telomerase complex. Proc Natl Acad Sci USA. 2009;106:18780\u20135. https:\/\/doi.org\/10.1073\/pnas.0906357106.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2042_CR68","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ijmm.2013.06.001","volume":"303","author":"I Padberg","year":"2013","unstructured":"Padberg I, Jan\u00dfen S, Meyer TF. Chlamydia trachomatis inhibits telomeric DNA damage signaling via transient hTERT upregulation. Int J Med Microbiol. 2013;303:463\u201374. https:\/\/doi.org\/10.1016\/j.ijmm.2013.06.001.","journal-title":"Int J Med Microbiol"},{"key":"2042_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106398","volume":"140","author":"P Boscolo-Rizzo","year":"2023","unstructured":"Boscolo-Rizzo P, Tirelli G, Polesel J, Sia E, Phillips V, Borsetto D, et al. TERT promoter mutations in head and neck squamous cell carcinoma: a systematic review and meta-analysis on prevalence and prognostic significance. Oral Oncol. 2023;140:106398. https:\/\/doi.org\/10.1016\/j.oraloncology.2023.106398.","journal-title":"Oral Oncol"},{"key":"2042_CR70","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1200\/jco.2011.36.4596","volume":"29","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML. Human papillomavirus and rising oropharyngeal cancer incidence in the united States. J Clin Oncol. 2011;29:4294\u2013301. https:\/\/doi.org\/10.1200\/jco.2011.36.4596.","journal-title":"J Clin Oncol"},{"key":"2042_CR71","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/jnci\/djy084","volume":"111","author":"B Trabert","year":"2019","unstructured":"Trabert B, Waterboer T, Idahl A, Brenner N, Brinton LA, Butt J, Coburn SB, Hartge P, Hufnagel K, Inturrisi F, Lissowska J, Mentzer A, Peplonska B, Sherman ME, Wills GS, Woodhall SC, Pawlita M, Wentzensen N. Antibodies against chlamydia trachomatis and ovarian cancer risk in two independent populations. J Natl Cancer Inst. 2019;111:129\u201336. https:\/\/doi.org\/10.1093\/jnci\/djy084.","journal-title":"J Natl Cancer Inst"},{"key":"2042_CR72","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/ijc.32999","volume":"147","author":"A Idahl","year":"2020","unstructured":"Idahl A, Le Cornet C, Gonz\u00e1lez Maldonado S, Waterboer T, Bender N, Tj\u00f8nneland A, et al. Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: results from the EPIC cohort. Int J Cancer. 2020;147:2042\u201352. https:\/\/doi.org\/10.1002\/ijc.32999.","journal-title":"Int J Cancer"},{"key":"2042_CR73","doi-asserted-by":"publisher","DOI":"10.5402\/2011\/436936","volume":"2011","author":"MT Mascellino","year":"2011","unstructured":"Mascellino MT, Boccia P, Oliva A. Immunopathogenesis in Chlamydia trachomatis infected women. ISRN Obstet Gynecol. 2011;2011:436936. https:\/\/doi.org\/10.5402\/2011\/436936.","journal-title":"ISRN Obstet Gynecol"},{"issue":"1","key":"2042_CR74","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00018-004-4367-6","volume":"62","author":"V Di Felice","year":"2005","unstructured":"Di Felice V, David S, Cappello F, Farina F, Zummo G. Is chlamydial heat shock protein 60 a risk factor for oncogenesis? Cell Mol Life Sci. 2005;62(1):4\u20139. https:\/\/doi.org\/10.1007\/s00018-004-4367-6.","journal-title":"Cell Mol Life Sci"},{"key":"2042_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-9-30","volume":"9","author":"S Seraceni","year":"2014","unstructured":"Seraceni S, De Seta F, Colli C, Del Savio R, Pesel G, Zanin V, et al. High prevalence of hpv multiple genotypes in women with persistent chlamydia trachomatis infection. Infect Agent Cancer. 2014;9:30. https:\/\/doi.org\/10.1186\/1750-9378-9-30.","journal-title":"Infect Agent Cancer"},{"key":"2042_CR76","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1021\/acsinfecdis.0c00839","volume":"7","author":"F Borella","year":"2021","unstructured":"Borella F, Carosso AR, Cosma S, Preti M, Collemi G, Cassoni P, et al. Gut microbiota and gynecological cancers: a summary of pathogenetic mechanisms and future directions. ACS Infect Dis. 2021;7:987\u20131009.","journal-title":"ACS Infect Dis"},{"key":"2042_CR77","doi-asserted-by":"publisher","first-page":"8645","DOI":"10.1038\/srep08645","volume":"5","author":"P Roos","year":"2015","unstructured":"Roos P, Orlando PA, Fagerstrom RM, Pepper JW. In North America, some ovarian cancers express the oncogenes of preventable human papillomavirus HPV-18. Sci Rep. 2015;5:8645. https:\/\/doi.org\/10.1038\/srep08645.","journal-title":"Sci Rep"},{"key":"2042_CR78","doi-asserted-by":"publisher","first-page":"e0294448","DOI":"10.1371\/journal.pone.0294448","volume":"18","author":"SE Robertson","year":"2023","unstructured":"Robertson SE, Yasukawa M, Marchion DC, Xiong Y, Naqvi SMH, Gheit T, et al. Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes. PLoS One. 2023;18:e0294448. https:\/\/doi.org\/10.1371\/journal.pone.0294448.","journal-title":"PLoS One"},{"key":"2042_CR79","first-page":"121","volume":"36","author":"OO Bilyk","year":"2014","unstructured":"Bilyk OO, Pande NT, Pejovic T, Buchinska LG. The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer. Exp Oncol. 2014;36:121\u20134.","journal-title":"Exp Oncol"},{"key":"2042_CR80","doi-asserted-by":"publisher","first-page":"19935","DOI":"10.1038\/s41598-019-56448-1","volume":"9","author":"E Paradowska","year":"2019","unstructured":"Paradowska E, Jab\u0142o\u0144ska A, Studzi\u0144ska M, Wilczy\u0144ski M, Wilczy\u0144ski JR. Detection and genotyping of CMV and HPV in tumors and fallopian tubes from epithelial ovarian cancer patients. Sci Rep. 2019;9:19935. https:\/\/doi.org\/10.1038\/s41598-019-56448-1.","journal-title":"Sci Rep"},{"key":"2042_CR81","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.2147\/cmarS262678","volume":"12","author":"X Yang","year":"2020","unstructured":"Yang X, You Q, Yao G, Geng J, Ma R, Meng H. Evaluation of p16 in epithelial ovarian cancer for a 10-year study in Northeast China: significance of HPV in correlation with PD-L1 expression. Cancer Manag Res. 2020;12:6747\u201353. https:\/\/doi.org\/10.2147\/cmarS262678.","journal-title":"Cancer Manag Res"},{"key":"2042_CR82","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.4049\/jimmunol.1502027","volume":"196","author":"TM Garcia-Bates","year":"2016","unstructured":"Garcia-Bates TM, Kim E, Concha-Benavente F, Trivedi S, Mailliard RB, Gambotto A, et al. Enhanced cytotoxic CD8 T cell priming using dendritic cell-expressing human Papillomavirus-16 E6\/E7-p16INK4 fusion protein with sequenced anti-programmed death-1. J Immunol. 2016;196:2870\u20138. https:\/\/doi.org\/10.4049\/jimmunol.1502027.","journal-title":"J Immunol"},{"key":"2042_CR83","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fimmu.2019.00356","volume":"10","author":"LR Sanchez","year":"2019","unstructured":"Sanchez LR, Godoy GJ, Gorosito Serr\u00e1n M, Breser ML, Fiocca Vernengo F, Engel P, Motrich RD, Gruppi A, Rivero VE. IL-10 producing B cells dampen protective T cell response and allow chlamydia muridarum infection of the male genital tract. Front Immunol. 2019;10:356. https:\/\/doi.org\/10.3389\/fimmu.2019.00356.","journal-title":"Front Immunol"},{"key":"2042_CR84","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s10096-021-04282-7","volume":"40","author":"S Cherif","year":"2021","unstructured":"Cherif S, Amine A, Thies S, Taube ET, Braicu EI, Sehouli J, Kaufmann AM. Prevalence of human papillomavirus detection in ovarian cancer: a meta-analysis. Eur J Clin Microbiol Infect Dis. 2021;40:1791\u2013802. https:\/\/doi.org\/10.1007\/s10096-021-04282-7.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2042_CR85","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.tranon.2018.02.008","volume":"11","author":"S Jonsson","year":"2018","unstructured":"Jonsson S, Oda H, Lundin E, Olsson J, Idahl A. Chlamydia trachomatis, chlamydial heat shock protein 60 and anti-chlamydial antibodies in women with epithelial ovarian tumors. Transl Oncol. 2018;11:546\u201351. https:\/\/doi.org\/10.1016\/j.tranon.2018.02.008.","journal-title":"Transl Oncol"},{"key":"2042_CR86","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4161\/rna.8.4.16019","volume":"8","author":"Y Yuva-Aydemir","year":"2011","unstructured":"Yuva-Aydemir Y, Simkin A, Gascon E, Gao FB. MicroRNA-9: functional evolution of a conserved small regulatory RNA. RNA Biol. 2011;8:557\u201364. https:\/\/doi.org\/10.4161\/rna.8.4.16019.","journal-title":"RNA Biol"},{"key":"2042_CR87","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1126\/science","volume":"248","author":"BA Werness","year":"1990","unstructured":"Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248:76\u20139. https:\/\/doi.org\/10.1126\/science.","journal-title":"Science"},{"key":"2042_CR88","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4143\/crt2005.37.6.319","volume":"37","author":"EK Yim","year":"2005","unstructured":"Yim EK, Park JS. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat. 2005;37:319\u201324. https:\/\/doi.org\/10.4143\/crt2005.37.6.319.","journal-title":"Cancer Res Treat"},{"key":"2042_CR89","doi-asserted-by":"publisher","unstructured":"Kudela E, Kudelova E, Kozub\u00edk E, Rokos T, Pribulova T, Holubekova V, Biringer K. HPV-Associated breast cancer: myth or fact? Pathogens. 2022;11. https:\/\/doi.org\/10.3390\/pathogens11121510 .","DOI":"10.3390\/pathogens11121510"},{"key":"2042_CR90","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1093\/cid\/ciz606","volume":"70","author":"M Masi\u00e1","year":"2020","unstructured":"Masi\u00e1 M, Fern\u00e1ndez-Gonz\u00e1lez M, Garc\u00eda JA, Padilla S, Garc\u00eda-Pay\u00e1 E, Guti\u00e9rrez A, et al. Infection with chlamydia trachomatis increases the risk of high-grade anal intraepithelial neoplasia in people living with human immunodeficiency virus. Clin Infect Dis. 2020;70:2161\u20137. https:\/\/doi.org\/10.1093\/cid\/ciz606.","journal-title":"Clin Infect Dis"},{"key":"2042_CR91","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.4049\/jimmunol.181.3.2092","volume":"181","author":"H Qiu","year":"2008","unstructured":"Qiu H, Fan Y, Joyee AG, Wang S, Han X, Bai H, et al. Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages. J Immunol. 2008;181:2092\u2013102.","journal-title":"J Immunol"},{"key":"2042_CR92","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1084\/jem.20040712","volume":"200","author":"RM O\u2019Connell","year":"2004","unstructured":"O\u2019Connell RM, Saha SK, Vaidya SA, Bruhn KW, Miranda GA, Zarnegar B, et al. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med. 2004;200:437\u201345. https:\/\/doi.org\/10.1084\/jem.20040712.","journal-title":"J Exp Med"},{"key":"2042_CR93","doi-asserted-by":"publisher","unstructured":"Stepp WH, Meyers JM, McBride AA. Sp100 provides intrinsic immunity against human papillomavirus infection. mBio. 2013;4:e00845-13. https:\/\/doi.org\/10.1128\/mBio.00845\u221213","DOI":"10.1128\/mBio.00845\u221213"},{"key":"2042_CR94","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12985-015-0335-z","volume":"12","author":"P Kivip\u00f5ld","year":"2015","unstructured":"Kivip\u00f5ld P, V\u00f5sa L, Ustav M, Kurg R. DAXX modulates human papillomavirus early gene expression and genome replication in U2OS cells. Virol J. 2015;12:104. https:\/\/doi.org\/10.1186\/s12985-015-0335-z.","journal-title":"Virol J"},{"key":"2042_CR95","doi-asserted-by":"publisher","first-page":"698840","DOI":"10.3389\/fcimb.2021.698840","volume":"11","author":"H Chen","year":"2021","unstructured":"Chen H, Wang L, Zhao L, Luo L, Min S, Wen Y, et al. Alterations of vaginal microbiota in women with infertility and chlamydia trachomatis infection. Front Cell Infect Microbiol. 2021;11:698840. https:\/\/doi.org\/10.3389\/fcimb.2021.698840.","journal-title":"Front Cell Infect Microbiol"},{"key":"2042_CR96","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.eimc2014.05.014","volume":"33","author":"MdelC Col\u00edn-Ferreyra","year":"2015","unstructured":"Col\u00edn-Ferreyra Mdel C, Mendieta-Zer\u00f3n H, Romero-Figueroa Mdel S, Mart\u00ednez-Madrigal M, Mart\u00ednez-P\u00e9rez S, Dom\u00ednguez-Garc\u00eda MV. Expression of gamma interferon during HPV and Chlamydia trachomatis infection in cervical samples. Enferm Infecc Microbiol Clin. 2015;33:105\u20139. https:\/\/doi.org\/10.1016\/j.eimc2014.05.014.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2042_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-6-20","volume":"6","author":"P Srivastava","year":"2008","unstructured":"Srivastava P, Jha R, Bas S, Salhan S, Mittal A. In infertile women, cells from Chlamydia trachomatis infected sites release higher levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha upon heat-shock-protein stimulation than fertile women. Reprod Biol Endocrinol. 2008;6:20. https:\/\/doi.org\/10.1186\/1477-7827-6-20.","journal-title":"Reprod Biol Endocrinol"},{"key":"2042_CR98","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5114\/ceji.2015.56969","volume":"41","author":"AC Nsonwu-Anyanwu","year":"2016","unstructured":"Nsonwu-Anyanwu AC, Charles-Davies MA, Bello FA, Taiwo VO, Bin L, Oni AA. Cytokine profile in Nigerians with tubal infertility. Cent Eur J Immunol. 2016;41:101\u20136. https:\/\/doi.org\/10.5114\/ceji.2015.56969.","journal-title":"Cent Eur J Immunol"},{"key":"2042_CR99","doi-asserted-by":"publisher","first-page":"1539871","DOI":"10.3389\/fcimb.2025.1539871","volume":"15","author":"C Olivera","year":"2025","unstructured":"Olivera C, Paira DA, Olmedo A, Olmedo JJ, Tissera AD, Molina RI, Ferreyra FN, Martinez MS, Chocobar YA, Cuffini CG, Motrich RD, Rivero VE. HPV and co-infections: impacts on semen inflammation, oxidative stress, and sperm quality. Front Cell Infect Microbiol. 2025;15:1539871. https:\/\/doi.org\/10.3389\/fcimb.2025.1539871.","journal-title":"Front Cell Infect Microbiol"},{"key":"2042_CR100","doi-asserted-by":"publisher","first-page":"842644","DOI":"10.3389\/fpubh.2022.842644","volume":"10","author":"ZH Ye","year":"2022","unstructured":"Ye ZH, Chen S, Liu F, Cui ST, Liu ZZ, Jiang YJ, et al. Patterns of sexually transmitted co-infections and associated factors among men who have sex with men: a cross-sectional study in Shenyang, China. Front Public Health. 2022;10:842644. https:\/\/doi.org\/10.3389\/fpubh.2022.842644.","journal-title":"Front Public Health"},{"key":"2042_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57090862","author":"E P\u00e9rez-Soto","year":"2021","unstructured":"P\u00e9rez-Soto E, Fern\u00e1ndez-Mart\u00ednez E, Oros-Pantoja R, Medel-Flores O, Miranda-Covarrubias JC, S\u00e1nchez-Monroy V. Proinflammatory and oxidative stress states induced by human papillomavirus and Chlamydia trachomatis coinfection affect sperm quality in asymptomatic infertile men. Medicina (Kaunas). 2021. https:\/\/doi.org\/10.3390\/medicina57090862.","journal-title":"Medicina (Kaunas)"},{"key":"2042_CR102","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1096\/fasebj.5.11.1907934","volume":"5","author":"MW Taylor","year":"1991","unstructured":"Taylor MW, Feng GS. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 1991;5:2516\u201322.","journal-title":"FASEB J"},{"key":"2042_CR103","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/infdis\/jiad155","volume":"228","author":"SJ Jordan","year":"2023","unstructured":"Jordan SJ, Wilson L, Ren J, Gupta K, Barnes S, Geisler WM. Natural clearance of chlamydia trachomatis infection is associated with distinct differences in cervicovaginal metabolites. J Infect Dis. 2023;228:1119\u201326. https:\/\/doi.org\/10.1093\/infdis\/jiad155.","journal-title":"J Infect Dis"},{"key":"2042_CR104","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1128\/iai.62.9.3705-3711.1994","volume":"62","author":"WL Beatty","year":"1994","unstructured":"Beatty WL, Belanger TA, Desai AA, Morrison RP, Byrne GI. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun. 1994;62:3705\u201311. https:\/\/doi.org\/10.1128\/iai.62.9.3705-3711.1994.","journal-title":"Infect Immun"},{"key":"2042_CR105","doi-asserted-by":"publisher","first-page":"e0051322","DOI":"10.1128\/iai.00513-22","volume":"91","author":"CM Riffaud","year":"2023","unstructured":"Riffaud CM, Rucks EA, Ouellette SP. Tryptophan availability during persistence of chlamydia trachomatis directly impacts expression of chlamydial cell division proteins. Infect Immun. 2023;91:e0051322. https:\/\/doi.org\/10.1128\/iai.00513-22.","journal-title":"Infect Immun"},{"key":"2042_CR106","doi-asserted-by":"publisher","first-page":"e0163174","DOI":"10.1371\/journal.pone.0163174","volume":"11","author":"SP Sherchand","year":"2016","unstructured":"Sherchand SP, Ibana JA, Zea AH, Quayle AJ, Aiyar A. The High-risk human papillomavirus e6 oncogene exacerbates the negative effect of tryptophan starvation on the development of Chlamydia trachomatis. PLoS One. 2016;11:e0163174. https:\/\/doi.org\/10.1371\/journal.pone.0163174.","journal-title":"PLoS One"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-02042-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-025-02042-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-02042-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:06:13Z","timestamp":1777903573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-025-02042-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2042"],"URL":"https:\/\/doi.org\/10.1007\/s43032-025-02042-y","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: none.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}